FDA Inspection
Element Materials Technology Boston - Acton Inc.Element Materials Technology Boston - Acton Inc. – FDA Inspection, Aug 1, 2025
Record Details
This FDA Inspection record concerns Element Materials Technology Boston - Acton Inc., with an inspection on August 1, 2025, issued by the New England District Office, covering biologics.
- Inspection Date
- August 1, 2025
- Product Type
- Biologics
View Company Profile
ID · 72bf7a21-e2b6-4811-b6c2-b797e83e4e2e
Inspection Facts
- Inspection number
- 1277186
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.182Specific information required in individual logs
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Element Materials Technology Boston - Acton Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 4, 2026 | VAI | New England District Office | Drug Quality Assurance |
| January 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 9, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 10, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Element Materials Technology Boston - Acton Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.